nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—RNASE3—nose—cleft lip	0.217	0.435	CbGeAlD
Pranlukast—IL5—nose—cleft lip	0.197	0.395	CbGeAlD
Pranlukast—MUC2—embryo—cleft lip	0.0203	0.0408	CbGeAlD
Pranlukast—MUC2—telencephalon—cleft lip	0.0165	0.0332	CbGeAlD
Pranlukast—NFKB1—mouth—cleft lip	0.0163	0.0326	CbGeAlD
Pranlukast—MUC2—head—cleft lip	0.0103	0.0207	CbGeAlD
Pranlukast—NFKB1—telencephalon—cleft lip	0.00943	0.0189	CbGeAlD
Pranlukast—NFKB1—head—cleft lip	0.00588	0.0118	CbGeAlD
Pranlukast—CYSLTR1—head—cleft lip	0.00577	0.0116	CbGeAlD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—WNT3—cleft lip	0.00372	0.00742	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—IRF6—cleft lip	0.00368	0.00734	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TP63—cleft lip	0.00335	0.00668	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—MTR—cleft lip	0.00327	0.00653	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—SUMO1—cleft lip	0.00311	0.0062	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—MTR—cleft lip	0.00306	0.00611	CbGpPWpGaD
Pranlukast—TNF—TGF-beta Receptor Signaling—BMP4—cleft lip	0.00293	0.00584	CbGpPWpGaD
Pranlukast—TNF—Signaling events mediated by HDAC Class I—SUMO1—cleft lip	0.00292	0.00582	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—SUMO1—cleft lip	0.00285	0.00569	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TGFB3—cleft lip	0.00283	0.00564	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TGFB3—cleft lip	0.00277	0.00553	CbGpPWpGaD
Pranlukast—ABCC2—NRF2 pathway—EPHA3—cleft lip	0.00276	0.0055	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—WNT9B—cleft lip	0.00271	0.0054	CbGpPWpGaD
Pranlukast—NFKB1—Hair Follicle Development: Induction (Part 1 of 3)—FGFR2—cleft lip	0.00261	0.00521	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—MTR—cleft lip	0.0026	0.00519	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP63—cleft lip	0.00255	0.00509	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—MTR—cleft lip	0.00249	0.00497	CbGpPWpGaD
Pranlukast—NFKB1—Hair Follicle Development: Induction (Part 1 of 3)—FGFR1—cleft lip	0.00244	0.00486	CbGpPWpGaD
Pranlukast—NFKB1—Neural Crest Differentiation—FGF8—cleft lip	0.00241	0.00481	CbGpPWpGaD
Pranlukast—NFKB1—Neural Crest Differentiation—BMP4—cleft lip	0.00233	0.00465	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—MTHFR—cleft lip	0.00215	0.0043	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—WNT3—cleft lip	0.00215	0.00429	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TGFB3—cleft lip	0.00211	0.00422	CbGpPWpGaD
Pranlukast—NFKB1—Cardiac Hypertrophic Response—FGFR2—cleft lip	0.00211	0.0042	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ARHGAP29—cleft lip	0.00209	0.00416	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—NODAL—cleft lip	0.00202	0.00403	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—MTR—cleft lip	0.00198	0.00395	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—WNT9B—cleft lip	0.00193	0.00386	CbGpPWpGaD
Pranlukast—IL5—AP-1 transcription factor network—MYC—cleft lip	0.0019	0.00379	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IRF6—cleft lip	0.00184	0.00368	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—MTHFR—cleft lip	0.00175	0.0035	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—FGF7—cleft lip	0.00175	0.00349	CbGpPWpGaD
Pranlukast—IL5—Regulation of nuclear SMAD2/3 signaling—MYC—cleft lip	0.00169	0.00338	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—FGF7—cleft lip	0.00167	0.00333	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—MTHFR—cleft lip	0.00164	0.00327	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—FGF8—cleft lip	0.00161	0.00322	CbGpPWpGaD
Pranlukast—TNF—Cardiac Hypertrophic Response—FGFR2—cleft lip	0.0016	0.0032	CbGpPWpGaD
Pranlukast—NFKB1—Angiopoietin receptor Tie2-mediated signaling—FGF2—cleft lip	0.00155	0.00309	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—FGF7—cleft lip	0.00154	0.00308	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—FGF8—cleft lip	0.00154	0.00307	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—NODAL—cleft lip	0.00154	0.00307	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—WNT3—cleft lip	0.00154	0.00307	CbGpPWpGaD
Pranlukast—NFKB1—Angiopoietin receptor Tie2-mediated signaling—NOS3—cleft lip	0.00153	0.00304	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—FGFR2—cleft lip	0.0015	0.00299	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ARHGAP29—cleft lip	0.0015	0.00299	CbGpPWpGaD
Pranlukast—IL5—Immune System—IRF6—cleft lip	0.00148	0.00296	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—EPHA3—cleft lip	0.00146	0.00292	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—BMP4—cleft lip	0.00145	0.00289	CbGpPWpGaD
Pranlukast—NFKB1—Cardiac Hypertrophic Response—FGF2—cleft lip	0.00143	0.00286	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—FGF8—cleft lip	0.00142	0.00284	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—MTHFR—cleft lip	0.00139	0.00278	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—WNT9B—cleft lip	0.00139	0.00277	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—MTHFR—cleft lip	0.00133	0.00266	CbGpPWpGaD
Pranlukast—NFKB1—CD40/CD40L signaling—MYC—cleft lip	0.00132	0.00262	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—FGF3—cleft lip	0.00131	0.00262	CbGpPWpGaD
Pranlukast—NFKB1—Neural Crest Differentiation—FGFR2—cleft lip	0.0013	0.00258	CbGpPWpGaD
Pranlukast—NFKB1—IL2 signaling events mediated by PI3K—MYC—cleft lip	0.00129	0.00257	CbGpPWpGaD
Pranlukast—ABCC2—NRF2 pathway—TGFA—cleft lip	0.00128	0.00256	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—FGF9—cleft lip	0.00128	0.00255	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—SUMO1—cleft lip	0.00126	0.00252	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—FGF3—cleft lip	0.00125	0.0025	CbGpPWpGaD
Pranlukast—NFKB1—AGE/RAGE pathway—NOS3—cleft lip	0.00122	0.00244	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—FGF9—cleft lip	0.00122	0.00244	CbGpPWpGaD
Pranlukast—NFKB1—Neural Crest Differentiation—FGFR1—cleft lip	0.00121	0.00241	CbGpPWpGaD
Pranlukast—TNF—Angiopoietin receptor Tie2-mediated signaling—FGF2—cleft lip	0.00118	0.00235	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—PTCH1—cleft lip	0.00118	0.00235	CbGpPWpGaD
Pranlukast—NFKB1—Hair Follicle Development: Induction (Part 1 of 3)—MYC—cleft lip	0.00116	0.00232	CbGpPWpGaD
Pranlukast—TNF—Angiopoietin receptor Tie2-mediated signaling—NOS3—cleft lip	0.00116	0.00232	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—FGF3—cleft lip	0.00116	0.00231	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—FGFR2—cleft lip	0.00114	0.00228	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—WNT9B—cleft lip	0.00114	0.00228	CbGpPWpGaD
Pranlukast—NFKB1—Neural Crest Differentiation—FGFR3—cleft lip	0.00114	0.00228	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—FGF7—cleft lip	0.00114	0.00227	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—FGF9—cleft lip	0.00113	0.00226	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—EPHA3—cleft lip	0.00112	0.00223	CbGpPWpGaD
Pranlukast—NFKB1—Leptin signaling pathway—NOS3—cleft lip	0.0011	0.0022	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—WNT3—cleft lip	0.0011	0.0022	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NOG—cleft lip	0.0011	0.00219	CbGpPWpGaD
Pranlukast—TNF—Cardiac Hypertrophic Response—FGF2—cleft lip	0.00109	0.00218	CbGpPWpGaD
Pranlukast—NFKB1—Aryl Hydrocarbon Receptor—MYC—cleft lip	0.00108	0.00216	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—FGF10—cleft lip	0.00108	0.00215	CbGpPWpGaD
Pranlukast—NFKB1—TSLP Signaling Pathway—MYC—cleft lip	0.00106	0.00212	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—MTHFR—cleft lip	0.00106	0.00212	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—FGF8—cleft lip	0.00105	0.00209	CbGpPWpGaD
Pranlukast—NFKB1—Ceramide signaling pathway—MYC—cleft lip	0.00105	0.00209	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—FGF10—cleft lip	0.00103	0.00206	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—FGF2—cleft lip	0.00102	0.00204	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ABCA4—cleft lip	0.00102	0.00203	CbGpPWpGaD
Pranlukast—IL5—Immune System—SUMO1—cleft lip	0.00102	0.00203	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—FGF10—cleft lip	0.000953	0.0019	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—NODAL—cleft lip	0.000943	0.00188	CbGpPWpGaD
Pranlukast—NFKB1—Corticotropin-releasing hormone—NOS3—cleft lip	0.000937	0.00187	CbGpPWpGaD
Pranlukast—IL5—Immune System—FGF7—cleft lip	0.000929	0.00185	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—WNT3—cleft lip	0.000908	0.00181	CbGpPWpGaD
Pranlukast—NFKB1—Neural Crest Differentiation—FGF2—cleft lip	0.000882	0.00176	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—FGFR2—cleft lip	0.000866	0.00173	CbGpPWpGaD
Pranlukast—NFKB1—Notch Signaling Pathway—MYC—cleft lip	0.000863	0.00172	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.000857	0.00171	CbGpPWpGaD
Pranlukast—IL5—Immune System—FGF8—cleft lip	0.000857	0.00171	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—FGF3—cleft lip	0.000853	0.0017	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ARHGAP29—cleft lip	0.000848	0.00169	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—PTCH1—cleft lip	0.000842	0.00168	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—FGF9—cleft lip	0.000832	0.00166	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—FGFR2—cleft lip	0.000827	0.00165	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor—MYC—cleft lip	0.000824	0.00164	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—WNT9B—cleft lip	0.00082	0.00164	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—FGFR1—cleft lip	0.000807	0.00161	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—FGFR1—cleft lip	0.000803	0.0016	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—MYC—cleft lip	0.0008	0.0016	CbGpPWpGaD
Pranlukast—TNF—Ceramide signaling pathway—MYC—cleft lip	0.000796	0.00159	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of Telomerase—MYC—cleft lip	0.000791	0.00158	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NOG—cleft lip	0.000786	0.00157	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—FGF2—cleft lip	0.000778	0.00155	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—FGFR1—cleft lip	0.000771	0.00154	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—FGFR2—cleft lip	0.000765	0.00153	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—cleft lip	0.000763	0.00152	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—ABCA4—cleft lip	0.000751	0.0015	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ABCA4—cleft lip	0.000731	0.00146	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—FGFR3—cleft lip	0.000728	0.00145	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.000725	0.00145	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—NODAL—cleft lip	0.000719	0.00143	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—FGFR1—cleft lip	0.000713	0.00142	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—FGF10—cleft lip	0.000702	0.0014	CbGpPWpGaD
Pranlukast—IL5—Immune System—FGF3—cleft lip	0.000698	0.00139	CbGpPWpGaD
Pranlukast—IL5—Immune System—FGF9—cleft lip	0.00068	0.00136	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—FGFR3—cleft lip	0.000674	0.00134	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—MYC—cleft lip	0.000668	0.00133	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.000653	0.0013	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—WNT3—cleft lip	0.000652	0.0013	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—FGF7—cleft lip	0.000648	0.00129	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—FGF7—cleft lip	0.000622	0.00124	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—NOS3—cleft lip	0.000617	0.00123	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—FGFR1—cleft lip	0.000612	0.00122	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—PTCH1—cleft lip	0.000604	0.00121	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IRF6—cleft lip	0.000602	0.0012	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—FGF7—cleft lip	0.0006	0.0012	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SPRY2—cleft lip	0.0006	0.0012	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—FGF8—cleft lip	0.000598	0.00119	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Receptor Signaling Pathway—MYC—cleft lip	0.000595	0.00119	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—FGF2—cleft lip	0.00059	0.00118	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—NOS3—cleft lip	0.00059	0.00118	CbGpPWpGaD
Pranlukast—NFKB1—Neural Crest Differentiation—MYC—cleft lip	0.000576	0.00115	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—FGF8—cleft lip	0.000574	0.00115	CbGpPWpGaD
Pranlukast—IL5—Immune System—FGF10—cleft lip	0.000574	0.00114	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—FGFR2—cleft lip	0.000563	0.00112	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—FGF2—cleft lip	0.000563	0.00112	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—FGF8—cleft lip	0.000554	0.00111	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.000552	0.0011	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—MYC—cleft lip	0.000542	0.00108	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.00053	0.00106	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—FGFR1—cleft lip	0.000525	0.00105	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—FGF2—cleft lip	0.000521	0.00104	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—MYC—cleft lip	0.000509	0.00102	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PTCH1—cleft lip	0.000498	0.000993	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—FGFR3—cleft lip	0.000496	0.00099	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—FGF3—cleft lip	0.000487	0.000971	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—FGF9—cleft lip	0.000475	0.000947	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—MTR—cleft lip	0.000475	0.000947	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—FGF3—cleft lip	0.000467	0.000933	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—WNT9B—cleft lip	0.000464	0.000927	CbGpPWpGaD
Pranlukast—IL5—Immune System—FGFR2—cleft lip	0.00046	0.000919	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—FGF9—cleft lip	0.000456	0.000909	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—FGF10—cleft lip	0.000453	0.000904	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—FGF3—cleft lip	0.000451	0.0009	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NOG—cleft lip	0.000445	0.000888	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—FGF9—cleft lip	0.00044	0.000877	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FGF7—cleft lip	0.000431	0.00086	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SPRY2—cleft lip	0.000431	0.00086	CbGpPWpGaD
Pranlukast—IL5—Immune System—FGFR1—cleft lip	0.000429	0.000856	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—MYC—cleft lip	0.000418	0.000834	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ABCA4—cleft lip	0.000414	0.000826	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—SUMO1—cleft lip	0.000413	0.000823	CbGpPWpGaD
Pranlukast—IL5—Immune System—FGFR3—cleft lip	0.000406	0.000809	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000403	0.000805	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—FGF10—cleft lip	0.0004	0.000799	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FGF8—cleft lip	0.000398	0.000793	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—MYC—cleft lip	0.000388	0.000774	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—FGF10—cleft lip	0.000384	0.000767	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—MYC—cleft lip	0.000384	0.000765	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—FGF2—cleft lip	0.000383	0.000765	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FGF7—cleft lip	0.000377	0.000753	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—FGF10—cleft lip	0.000371	0.00074	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—WNT3—cleft lip	0.000369	0.000736	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PTCH1—cleft lip	0.000357	0.000712	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FGF8—cleft lip	0.000348	0.000695	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000346	0.000691	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—FGF10—cleft lip	0.000345	0.000689	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—FGFR1—cleft lip	0.000339	0.000676	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FGF3—cleft lip	0.000324	0.000646	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—FGFR2—cleft lip	0.000321	0.000641	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FGF9—cleft lip	0.000316	0.00063	CbGpPWpGaD
Pranlukast—IL5—Immune System—FGF2—cleft lip	0.000313	0.000625	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—MTR—cleft lip	0.000313	0.000624	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—FGFR2—cleft lip	0.000308	0.000615	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—FGFR1—cleft lip	0.000299	0.000597	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—FGFR2—cleft lip	0.000298	0.000594	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—MYC—cleft lip	0.000292	0.000583	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—FGFR1—cleft lip	0.000288	0.000574	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FGF3—cleft lip	0.000283	0.000566	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—FGFR3—cleft lip	0.000283	0.000565	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—FGFR1—cleft lip	0.000277	0.000554	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FGF9—cleft lip	0.000276	0.000552	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—FGFR3—cleft lip	0.000272	0.000542	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FGF10—cleft lip	0.000266	0.000531	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000264	0.000526	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—FGFR3—cleft lip	0.000262	0.000523	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—FGFR1—cleft lip	0.000258	0.000515	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—FGF2—cleft lip	0.000248	0.000494	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FGF7—cleft lip	0.000244	0.000487	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SPRY2—cleft lip	0.000244	0.000487	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FGF10—cleft lip	0.000233	0.000465	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FGF8—cleft lip	0.000225	0.000449	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—FGF2—cleft lip	0.000219	0.000436	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FGFR2—cleft lip	0.000214	0.000426	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—FGF2—cleft lip	0.00021	0.000419	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—FGF2—cleft lip	0.000203	0.000404	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PTCH1—cleft lip	0.000202	0.000403	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NOS3—cleft lip	0.0002	0.000399	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FGFR1—cleft lip	0.000199	0.000397	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—FGF2—cleft lip	0.000189	0.000376	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FGFR3—cleft lip	0.000188	0.000375	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FGFR2—cleft lip	0.000187	0.000373	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FGF3—cleft lip	0.000183	0.000366	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FGF9—cleft lip	0.000179	0.000357	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FGFR1—cleft lip	0.000174	0.000348	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FGFR3—cleft lip	0.000165	0.000329	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FGF10—cleft lip	0.000151	0.000301	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FGF2—cleft lip	0.000145	0.00029	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NOS3—cleft lip	0.000143	0.000286	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC19A1—cleft lip	0.000141	0.000282	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MYC—cleft lip	0.000132	0.000264	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FGF2—cleft lip	0.000127	0.000254	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FGFR2—cleft lip	0.000121	0.000241	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TCN2—cleft lip	0.000117	0.000234	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FGFR1—cleft lip	0.000113	0.000225	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FGFR3—cleft lip	0.000107	0.000213	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MYC—cleft lip	9.51e-05	0.00019	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC19A1—cleft lip	9.32e-05	0.000186	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FGF2—cleft lip	8.23e-05	0.000164	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NOS3—cleft lip	8.12e-05	0.000162	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MTR—cleft lip	8.12e-05	0.000162	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TCN2—cleft lip	7.72e-05	0.000154	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MYC—cleft lip	5.38e-05	0.000107	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MTR—cleft lip	5.35e-05	0.000107	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TYMS—cleft lip	4.97e-05	9.92e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MTHFR—cleft lip	4.35e-05	8.67e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TYMS—cleft lip	3.28e-05	6.55e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NOS3—cleft lip	3.03e-05	6.05e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MTHFR—cleft lip	2.87e-05	5.72e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NOS3—cleft lip	2e-05	3.99e-05	CbGpPWpGaD
